Atlas Trials

Solid Tumor, Unspecified, Adult

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Solid Tumor, Unspecified, Adult

RecordFirmDate
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors (NCT04643418)MegaPro Biomedical Co. Ltd.2022-03-08
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors (NCT04577963)Hutchmed2021-08-09
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values (NCT04942717)Memorial Sloan Kettering Cancer Center2021-06-18
Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein (NCT04976803)Artios Pharma Ltd2021-05-28
Gustave Roussy Cancer Profiling (NCT04932525)Gustave Roussy, Cancer Campus, Grand Paris2021-05-10
Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment (NCT05695638)Morten Ladekarl2020-07-01
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors (NCT04443088)Shenzhen Ionova Life Sciences Co., Ltd.2020-06-26
Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors (NCT04169321)Cytosite Biopharma Inc.2020-06-16
Psychotherapy Intervention for Latinos With Adv Cancer (NCT04537936)Memorial Sloan Kettering Cancer Center2019-01-01
A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies (NCT03628677)Arcus Biosciences, Inc.2018-09-12
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair (NCT03318445)Pamela Munster2018-01-12
Psychotherapy Intervention for Latinos With Advanced Cancer (NCT04015609)Memorial Sloan Kettering Cancer Center2015-04-20

Track Solid Tumor, Unspecified, Adult automatically

Every clearance here is in the API, with alerts when new ones post.